Proactive Investors
14 Oct 2026, 07:24 UTC · 2h ago
Cellbxhealth signs new statement of work with US pharma company
Impact · against what's priced in
The news for Cellbxhealth is mildly positive as it provides a concrete unit economic benchmark ($650/sample) for its platform, though the total contract value is small. Buccaneer Energy's capital raise and cash flow updates are standard operational updates with limited immediate price impact.
- CLBX+0.20
No priced-in read yet
- In context
The agreement for 100 samples worth $65,000 establishes a specific revenue data point of ~$650 per sample for the Parsortix platform, supporting the company's goal of sustainable revenue growth.
Read from the article alone
Search tags
